Disturbed expression of autophagy genes in blood of Parkinson's disease patients.


Journal

Gene
ISSN: 1879-0038
Titre abrégé: Gene
Pays: Netherlands
ID NLM: 7706761

Informations de publication

Date de publication:
15 May 2020
Historique:
received: 03 09 2019
revised: 17 01 2020
accepted: 04 02 2020
pubmed: 9 2 2020
medline: 28 4 2020
entrez: 9 2 2020
Statut: ppublish

Résumé

Parkinson's disease (PD) is a common neurodegenerative disorder which affects dopaminergic neurons leading to alteration of numerous cellular pathways. Several reports highlight that PD disturbs also other cells than CNS neurons including PBMCs, which could lead, among other things, to dysfunctions of immune functions. Because autophagy could be altered in PD, a monocentric pilot study was performed to quantify the transcripts levels of several autophagy genes in blood cells. MAP1LC3B, GABARAP, GABARAPL1, GABARAPL2 and P62/SQSTM1 were found to be overexpressed in patients. On the contrary, transcripts for HSPA8 and GAPDH were both decreased. Expression of MAP1LC3B and GABARAP was able to successfully segregate PD patients from healthy controls. The accuracy of this segregation was substantially increased when combined expressions of MAP1LC3B and GAPDH or GABARAP and GAPDH were used as categorical variables. This pilot study suggests that autophagy genes expression is dysregulated in PD patients and may open new perspectives for the characterisation of prediction markers.

Identifiants

pubmed: 32035240
pii: S0378-1119(20)30123-2
doi: 10.1016/j.gene.2020.144454
pii:
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
Apoptosis Regulatory Proteins 0
Biomarkers 0
GABARAP protein, human 0
GABARAPL1 protein, human 0
MAP1LC3B protein, human 0
Microtubule-Associated Proteins 0
SQSTM1 protein, human 0
Sequestosome-1 Protein 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

144454

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Saïd El Haddad (S)

Centre de Biophysique Moléculaire, CNRS UPR 4301, Affiliated with the Université d'Orléans - Pôle Universitaire Centre Val de Loire, Rue Charles Sadron, 45071 Orléans Cedex 2, France.

Amandine Serrano (A)

Centre de Biophysique Moléculaire, CNRS UPR 4301, Affiliated with the Université d'Orléans - Pôle Universitaire Centre Val de Loire, Rue Charles Sadron, 45071 Orléans Cedex 2, France.

Frédéric Moal (F)

LIFO Bat. 3IA, Université d'Orléans, Rue Léonard de Vinci, B.P. 6759F-45067 Orleans Cedex 2, France.

Thierry Normand (T)

Centre de Biophysique Moléculaire, CNRS UPR 4301, Affiliated with the Université d'Orléans - Pôle Universitaire Centre Val de Loire, Rue Charles Sadron, 45071 Orléans Cedex 2, France.

Chloé Robin (C)

Centre de Biophysique Moléculaire, CNRS UPR 4301, Affiliated with the Université d'Orléans - Pôle Universitaire Centre Val de Loire, Rue Charles Sadron, 45071 Orléans Cedex 2, France.

Stéphane Charpentier (S)

Centre de Biophysique Moléculaire, CNRS UPR 4301, Affiliated with the Université d'Orléans - Pôle Universitaire Centre Val de Loire, Rue Charles Sadron, 45071 Orléans Cedex 2, France.

Antoine Valery (A)

Département d'Information Médicale, Centre Hospitalier Régional d'Orléans-La Source CHRO, Orléans, France.

Fabienne Brulé-Morabito (F)

Centre de Biophysique Moléculaire, CNRS UPR 4301, Affiliated with the Université d'Orléans - Pôle Universitaire Centre Val de Loire, Rue Charles Sadron, 45071 Orléans Cedex 2, France.

Pascal Auzou (P)

Service de Neurologie, Centre Hospitalier Régional d'Orléans-La Source CHRO, Orléans, France.

Lucile Mollet (L)

Centre de Biophysique Moléculaire, CNRS UPR 4301, Affiliated with the Université d'Orléans - Pôle Universitaire Centre Val de Loire, Rue Charles Sadron, 45071 Orléans Cedex 2, France.

Canan Ozsancak (C)

Service de Neurologie, Centre Hospitalier Régional d'Orléans-La Source CHRO, Orléans, France.

Alain Legrand (A)

Centre de Biophysique Moléculaire, CNRS UPR 4301, Affiliated with the Université d'Orléans - Pôle Universitaire Centre Val de Loire, Rue Charles Sadron, 45071 Orléans Cedex 2, France. Electronic address: alain.legrand@cnrs.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH